HDAC2 and cancer: Interestingly, although HDAC1 and HDAC2 suppress lymphomagenesis in a dosage-dependent manner, complete inactivation of HDAC1 and HDAC2 abrogates lymphomagenesis as some level of HDAC activity is required for cancer cell vulnerability.